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Previously, we  isolated  and  characterized  an  /-A-restricted  alloreactive T  helper 
(Tn) 1 component  from  an  allogeneic  effect  factor  (AEF)  produced  across  an  H-2 
incompatibility using graft-versus-host reaction (GVHR)-activated responder T  cells 
and irradiated stimulator spleen cells (1).  This AEF component was purported to be 
a  secreted form of a  T  cell Ia alloantigen receptor. In this report, we extended these 
studies by the characterization of the TH components of an AEF produced across the 
same H-2  incompatibility using GVHR-activated responder T  cells  and  irradiated 
stimulator T  cell-depleted spleen cells. The use of such a  stimulator cell population 
reduced  the  chance  that  any  detectable  /-A-restricted  AEF  TH  components  were 
products  of stimulator  T  cells  (2).  We  also  introduced  some  modifications  to  our 
method  of biochemical  fractionation  of AEF  that  enabled  us  to  detect  both  self- 
reactive and alloreactive/-A-restricted Tn components. Comparative functional and 
molecular  analyses  of  these  two  /-A-restricted  components  suggest  that  they  are 
structurally distinct responder T cell-derived Ia- molecules that recognize/-A-encoded 
determinants  on  antigen-presenting  cells  (APC)  of the  responder  and  stimulator 
haplotypes,  respectively.  The  data  are  discussed  in  terms of their  relevance  to  the 
molecular basis of T  cell alloreactivity. 
Materials and Methods 
Mice.  Mice used were bred and maintained at the University of Toronto. 
Antibodies.  Ascites fluids of the rat AF.3.44.4 (330 #g IgM/ml) and F 30.60 (16 mg IgG/ml) 
hybridomas produced upon  immunization with a  mouse keyhole limpet hemocyanin  (KLH)- 
specific T  cell  helper  factor  (TnF)  and  a  KLH-specific T  cell  suppressor  factor  (TsF)  (3), 
respectively, were  kindly  supplied  by  Dr.  R. James  and  Dr.  M.  Feldmann,  Department  of 
* Supported by grants MT 5729 and MA 5440 from the Medical Research Council of Canada. 
1 Abbreviations  used in this paper: AEF, allogeneic effect factor;  APC, antigen-presenting cell; BSA, bovine 
serum albumin; C', rabbit serum complement; I-D and 2-D, one and two dimensional; DTT, dlthiothreitol; 
GVHR,  graft-versus-host-reaction;  IEF,  isoelectric  focusing;  IL-2,  interleukin  2;  KLH,  keyhole  limpet 
hemocyanin; MLR, mixed lymphocyte reaction; MSA, mouse serum albumin; PBS, phosphate-buffered 
saline;  PFC,  plaque-forming cell;  pI, isoelectric  point;  SDS, sodium dodecyl sulfate;  SDS-PAGE, SDS- 
polyacrylamide gel electrophoresis;  SRBC, sheep erythrocyte; Tn, T helper cell; TnF, T cell helper factor; 
Ts, T  suppressor  cell, TsF, T  cell suppressor  factor;  TPCK,  L(tosylamide-2-phenyl)-ethyl-chloromethyl- 
ketone. 
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Zoology, University College, London, England. Affinity-purified F(ab')2 of rabbit anti-rat Fab 
(3 mg IgG/ml) was a kind gift from Dr. M. Letarte, Division of Immunology, Hospital for Sick 
Children,  Toronto,  Ontario,  Canada.  Goat  anti-rabbit IgG antiserum  was  purchased  from 
Miles  Laboratories Inc.,  Elkhart,  IN.  The  HO.13-4  monoclonal  anti-Thy-l.2  mouse  IgM- 
secreting hybridoma (4) used to prepare T cell-depleted spleen cells was obtained from the Salk 
Institute Cell Distribution Center, La Jolla, CA. Mouse anti-Lyt-1.2 and anti-Lyt-2.2 mono- 
elonal antibodies used to prepare B cell and APC suspensions were purchased from Cedarlane 
Laboratories, Hornby, Ontario. 
Preparation of Cells.  Suspensions of spleen cells that  were either depleted of T  cells (B  + 
APC), or otherwise highly enriched for either B cells or APC, were prepared as described (5). 
The B cell and APC suspensions consisted of 1-3% Thy- 1.2  +, ~1% Ig  ÷ cells and 1-2% Thy- 1.2  ÷, 
-->95% Ig  + cells, respectively (5). APC were irradiated with 3,000  tad before use (5). 
Preparation, Fractionation, and  Radioiodination of AEF.  AEF  was  produced  across  an  H-2 
incompatibility using GVHR-activated A.SW (H-28) responder T  cells and irradiated (3,000 
rad) A/WySn (H-2  a) stimulator spleen cells that were either depleted (i.e., treated with anti- 
Thy-1.2 plus complement [C']) or not depleted of T cells. Results obtained with AEF prepared 
with irradiated T  cell-depleted stimulator spleen cells are presented. Two different batches of 
AEF were used in this study and each one yielded similar results. As was previously observed 
(1, 6), ->90% of the activated responder T  cell population were serologicaily shown to be of 
donor  T  cell origin.  Thus,  the  use  of such  T  cell-enriched responder and  T  cell-depleted 
stimulator populations enhanced  the likelihood that  alloaetivated responder T  cells are the 
source of AEF-derived helper components. 
About 25 ml of unseparated serum-free AEF was concentrated to 5 ml and chromatographed 
at 4°C on Ultrogei ACA 54 (Fisher Scientific Co., Toronto, Ontario), equilibrated with sterile 
0.9% NaCI (1, 5). Selected biologically  active fractions (8 ml) were pooled, concentrated to 3 ml 
and further resolved by ehromatofocusing at 4°C on PBE 94 gel (Pharmacia Fine Chemicals, 
Dorval, Quebec, Canada) using 0.025 M  imidazole-HCl, pH 7, as start buffer and Polybuffer 
74-HC1  (Pharmacia Fine Chemicals), pH 4.0, as eluent (5, 7). Active fractions (8 ml) found in 
the pH 5.5-6.0 range were pooled and refocused on PBE 94 using the same start buffer and 
Polybuffer 74-HC1,  pH 5.0,  as eluent. Chromatofocused fractions were neutralized to pH 7.2, 
with 1 M  Tris base, pH 11, dialyzed vs. 0.04 M  NaCI, and concentrated 3-4-fold before assay. 
After fractionation, the yield of certain AEF components was estimated spectrofluorimetrieally, 
as described (5). 
About  250  ng  (4  pmol)  of the /-A-restricted AEF helper components obtained after the 
second step of chromatofocusing were radioacylated with ~I using the Bolton-Hunter reagent 
(>1,375  Ci/mmol sp act;  Amersham Corp.,  Oakville, Ontario)  and  then  further  processed 
before storage at -70°C as described (5). 
Biochemical Analysis of AEF.  Treatment with various enzymes (mercuripapain, neuramini- 
dase, alkaline phosphatase, trypsin), immunoprecipitation with protein A-Sepharose CL 4B 
(Pharmacia Fine Chemicals), one-dimensional (l-D) sodium dodecyl sulfate (SDS)-polyacryl- 
amide gel electrophoresis (SDS-PAGE), isoelectric focusing (IEF) on 1-D slab gels, and peptide 
mapping  on  IEF  tube  gels  of 12SI-labeled  /-A-restricted helper  components  of AEF  were 
performed exactly as described (5). 
Biological Assay of AEF.  After each step of biochemical fractionation of AEF, aliquots (70 
#l) of isolated fractions (8 ml) were assayed in triplicate at either a  1:3,  1:6, or 1:9 final dilution 
for their capacity to activate an~ in vitro primary anti-sheep erythrocyte (SRBC)  5-d direct 
plaque-forming cell (PFC)  response  (1).  SRBC  from a  single sheep  (sheep No.  5,  Woodlyn 
Laboratories, Guelph, Ontario) were used. Cultures (0.21 ml) in RPMI  1640 medium, supple- 
mented with 5% fetal calf serum, 5 ×  10  -5 M  2-mercaptoethanol, 4 mM glutamine, 100 U/ml 
penicillin, 100 ~g/ml streptomycin, and 40/xg/ml gentamycin, contained 106 SRBC as antigen 
and either 10  n T  cell-depleted B +  APC or 104 isolated APC and 5 ×  105 isolated B cells. 
Results 
Fractionation of AEF TH Components.  Fig.  1 A  shows  that  fractions of AEF eluting 
from ACA 54 in eight different mol wt ranges, designated pools I-VIII, displayed TH 1796  /-A-RESTRICTED ALLOGENEIC EFFECT FACTOR MOLECULES 
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FIc.  1.  (A)  Assay of AEF activity after  gel  filtration on ACA 54.  About 25  ml of AEF was 
concentrated to 5 ml and chromatographed on ACA 54. Column fractions (8 ml) were collected and 
assayed  at  1:9 dilution in a primary in vitro anti-SRBC direct  PFC response of either A/WySn 
(0) or A.SW (©) T cell-depleted  spleen cells (108). The positions of the molecular weight markers 
rabbit IgG (150,000), bovine serum albumin (86,000), ovalbumin (43,000), a-chymotrypsinogen 
(26,000) and cytochrome C (12,500) are indicated by arrows. The peaks of Tn activity observed are 
designated as pools I-VIII. (B) Assay of AEF activity after the first stage of chromatofocusing.  The 
/-A-restricted  ACA 54 pool  V  in (,4) was concentrated and ehromatofocused  on PBE  94 using 
Polybuffer 74-HC1, pH 4.0, as eluent. Fractions (8 ml) were neutralized, dialysed, concentrated, and 
assayed at a  1:6 dilution for their TH activity with either 10  e A/WySn (0) or A.SW (O) T  cell- 
depleted spleen cells. The peaks of TH activity are designated as pools I and II. 
activity for T  cell-depleted spleen cells of both  the stimulator and responder haplo- 
types.  By contrast to our previous identification of only two major pools of AEF TH 
activity upon  assay of the  fraction of responding microcultures  (1),  quantitation of 
direct PFC in the in vitro primary anti-SRBC responses illustrated here enabled us to 
detect  several  distinct pools of AEF TH activity. Interestingly, an H-2-restricted TH 
activity for A/WySn  lymphocytes (i.e., alloreactivity) was found to be associated only 
with  pool  V,  which  contained  components  in  the  50,000-70,000  mol  wt  range.  A 
strain  distribution analysis similar to  that  previously described  (7)  showed  this  TH 
activity to be I-A k restricted.  Little H-2-restricted Tn activity for A.SW lymphocytes 
(i.e., self-reactivity) was evident at this stage of AEF fractionation. 
Since ACA 54 pool V  of Fig.  1 A contained strong TH alloreactivity and very much DELOVITCH ET AL.  1797 
weaker TH self-reactivity, it was of interest to determine whether these two reactivities 
are mediated by the same or different components in this pool. Pool V  was therefore 
further fractionated by chromatofocusing. Fig.  1 B shows a chromatofocusing pattern 
of ACA  54  pool  V  obtained  using a  descending  pH  gradient  of 7.4-3.8.  The  TH 
activity observed appeared in the pH 5.4-6.0 range and fractions eluting in this range 
differed from each other by about 0.2 pH units.  A  sharp predominant  peak of TH 
alloreactivity for A/WySn T  cell-depleted spleen cells focused at an isoelectric point 
(pI) of ~5.8 (pool I), while a broader and lesser peak of Tn self-reactivity for A.SW T 
cell-depleted  spleen  cells  focused  at  pI  5.5  (pool  II).  These  data  suggested  that 
alloreactive and self-reactive TH components of AEF might be separable according to 
their difference in net molecular charge. 
Resolution  and  Target  Cell  of  Action  of  Alloreactive  and  Self-reactive  AEF  TH 
Components.  An  attempt  was  made  to improve the resolution of the putative allo- 
reactive and  self-reactive TH components of AEF and  to identify the target cell of 
action of these TH components.  Pools I  and  II of Fig.  1 B were rechromatofocused 
using a descending pH gradient of 7-5, which permitted the elution of fractions that 
differed by <0.1  pH units. The eluted fractions were assayed for their TH activity in 
the  presence  of either  syngeneic  or  allogeneic  mixtures  of isolated  B10.A  (H-2~; 
histocompatible with stimulator strain  (A/WySn) and B10.S (H-2S; histocompatible 
with responder strain A.SW) splenic APC and B cells. 
Fig.  2  illustrates  that  alloreactive and  self-reactive TH components of AEF were 
well resolved by this second step of chromatofocusing. The alloreactive component of 
about pI 5.8 was active in the presence of B 10.A APC and either syngeneic B 10.A or 
allogeneic B 10.S B cells. The self-reactive component of about pI 5.5 was active in the 
presence of B10.S APC and either syngeneic B10.S or allogeneic BI0.A B cells.  The 
self-reactive component  likely recognizes /-AS-encoded alloantigens  on  B10.S  APC 
since no I-E alloantigens are expressed by the H-2  s haplotype. For simplicity, these 
alloreactive pI 5.8  (Fig. 2, fractions  16-17)  and self-reactive pI 5.5  (fractions 20-21) 
AEF  components  will  be  designated  as  T~-I  and  T~-2,  respectively.  The  data 
indicate that T~-I  and T~-2  differ in  their pI  value and  that  their/-A-restricted 
activity is operative at the level of recognition of Ia molecules on an APC and not a 
B cell. 
Partial  strain  distribution  analyses  of  the  activity  of T~-I  and  TI~-2  have 
shown  that  APC  of strains  that  express I-A k or LA d  determinants  are required to 
detect T~-1  activity, whereas APC of strains that express I-A s or I-A d determinants 
are required to detect T~-2 activity (data not shown). No responses were obtained for 
either AEF TH component in the presence of APC of strains that express I-A b or I-A / 
determinants. The patterns of reactivity ofT~-1 and T~-2 are most likely attribut- 
able to structural homologies that exist between/-A-encoded Ia antigens of different 
haplotypes  (8).  Although  both T~-I  and T~-2  display  alloreactivity,  only T~-2 
exhibits self-reactivity for the responder haplotype APC  (Fig. 2).  We shall  therefore 
continue to refer to T~-2 as a  self-reactive component. T~- 1 and T~-2 were active 
only if added during the first 24 h of culture. A TH/APC interaction in the presence 
of antigen must therefore preempt B cell activation, differentiation, and Ig secretion. 
These  observations  are  compatible  with  our  tentative  conclusions  reached  earlier 
using a  less well purified ACA 54 column-fractionated/-A-restricted TH component 
of AEF (9). 1798  /-A-RESTRICTED  ALLOGENEIC EFFECT  FACTOR MOLECULES 
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FIG.  2.  Assay  of AEF activity after the second stage of chromatofoeusing. Pools I and II of Fig. 1  A 
were each concentrated and rechromatofocused on PBE 94 using Polybuffer 74-HC1, plq 5.0, as 
eluent. Fractions (8 ml) were tested at a  1:3 dilution for their Tn activity with 5 ×  105 B cells of 
either BI0.A (A) or B10.S (B) origin and APC (104) from each strain as shown. 
T~-I  and T~-2  are of limited  heterogeneity  in that  each  focused rather  sharply, 
with  their predominant  activity being present  in only two fractions  (Fig.  2).  Similar 
chromatofocusing patterns  were  previously obtained  for two/-J-restricted  AEF TH 
components  (5).  Purified  homogeneous  proteins  such  as  IgG  H  and  L  chains, 
hemoglobin, and ovalbumin also focus under similar conditions in three fractions. To 
estimate the degree of purification achieved for T~-1 and T~-2, we used a method of 
analysis  of total  activity  initially  devised  for  interleukin  2  (IL-2)  (10)  that  was 
subsequently  adapted  for AEF  (11).  The yields of T~-I  and T~-2  at  each stage of 
fractionation  were monitored spectrofluorimetrically  (8)  and were used  to calculate 
the specific activity of the various fractions. In this way, the extent of final purification 
of T~-I  was estimated  to be about 900-fold (Table I). A  similar result  was obtained 
for  T~-2  (not  shown).  This  level  of  purification  is  comparable  to  the  800-fold 
purification  reported  for /-J-restricted  AEF  TH  components  (5)  and  validates  the 
reproducibility of this method. 
Before fractionation,  the  25  ml of AEF contained  about  2.5  mg of total  protein. 
The yields of TZ~  - 1 and T~-2 after the second step of chromatofocusing were -2  and 
1 #g, respectively.  Since the greater proportion of the T  cells  (___90%) present  in the 
cultures used to produce AEF were of donor origin (see Materials  and Methods),  we 
assume that  both T~-I  and T~-2  are responder T  cell derived. To detect T~-I  and DELOVITCH  ET AL.  1799 
TABLE  I 
Purification of T~-I 
Total  Specific  Purifica-  Stage of fractionation  Protein  activity*  activity~  tion fold 
rag 
Unseparated AEF  2.5  150  60  1 
ACA 54  0.67  422  630  10.5 
Chromatofoeusing-  1  0.014  352  25,200  420 
Chromatofocusing-2  0.002  107  53,460  891 
* One unit of AEF activity was assigned to the amount present in 1 ml of a 
h 10 dilution of unseparated AEF. This dilution produced a response  of ~500 
direct PFC/107 cultured A,,rvVySn  T cell-depleted spleen cells and was used 
to compute the potency relative to the standard of unseparated AEF. The 
total activity of different fractions assayed by serial dilution was calculated 
at various stages of purification by multiplying the fraction volume by its 
potency relative to unseparated AEF. 
~: Specific activity = total activity/protein. 
TI~-2 activities, it is essential that alloactivated nonirradiated  dividing responder T 
cell blasts beused for the production ofAEF. Supernatants harvested after 16 h of co- 
culture ofnonactivated responder thymocytes and irradiated stimulator normal spleen 
cells did not elicit any/-A-restricted Tn activity (unpublished data). This lends further 
support to the notion that TI~  - 1 and TI~-2 are responder T  cell-derived. Insofar as 2.5 
X  10  s activated responder T  cells are required  to generate 25 ml of AEF, it follows 
that on the order of 1 #g of T~-I  and T~-2 are each secreted and/or shed from 10  s 
alloactivated T  cells. These yields are maximum estimates since, although TI~  - 1  and 
T~-2 were purified about  900-fold, they were presumably not  purified  to homoge- 
neity.  Nonetheless,  the  yields  obtained  concur  with  a  yield  of ~0.5  #g/10  a  cells 
expected  for a  eukaryotic plasma membrane-associated glycoprotein.  These  results 
also  imply  that  ~0.01%  of total  protein  synthesis  in  an  activated  T  cell  may be 
devoted to the synthesis of T~-1 and TI~-2. The accuracy of this estimate depends on 
whether these proteins may also be found in greater amount in a membrane-associated 
form and/or cytoplasmic form. Based on a  68,000  mol wt  for T~-I  and T~-2  (see 
Fig.  3), we deduce  that  these proteins are biologically active at  the level of 1 pmol 
(i.e., 80 pg) per culture of 104 APC and 5 ×  105 B cells. This picomolar concentration 
range of activity is very similar to that  previously found  for/-J-restricted AEF Trt 
components (5), IL-1 (11), and IL-2 (12). 
Biochemical and Serological Analysis of Ttan-I and Tt~-2.  Due to the existing intrigue 
concerning the functional and molecular interrelationship between T  cell alloreactiv- 
ity and self-reactivity, we wished to compare the structural properties of the alloreac- 
tive  TI~-I and  self-reactive T~-2  components. T~-I  and TmH-2 were characterized 
with respect to their size, subunit  structure,  sensitivity to proteolysis, charge hetero- 
geneity, tryptic peptide map, and expression of certain serological determinants. 
Aliquots of chromatofocused T~-1  and T~-2  (see Fig. 2) were radioiodinated  and 
analyzed by 1-D 10% SDS-PAGE under reducing conditions before and after digestion 
with  papain  (11,  13).  Before digestion,  T~-I  (Fig.  3A)  and T~-2  (Fig.  3B)  each 
migrated as a single polypeptide chain of about 68,000 tool wt; identical results were 
obtained  during  electrophoresis  under  reducing  conditions  (data  not  shown),  as 1800  /-A-RESTRICTED ALLOGENEIC EFFECT FACTOR  MOLECULES 
Flo.  3.  SDS-PAGE of IZSl-labeled  T~-I  and T~-2, Aliquots of chromatofocused T~-I  (lanes A 
and C) and T~-2 (lanes B and D) of Fig. 2 were radioiodinated, lyophilized, resuspended, and then 
incubated for l h at 37aC with 5 gg/ml of mercuripapain (enzyme/protein  =  l : 100) in 20 gl of PBS 
containing  [ mM dithiothreitol and 2.5% glycerol. Control samples were incubated in the absence 
of enzyme.  Samples  were  electrophoresed  before  (lanes  A  and  B)  and  after  (lanes  C  and  D) 
enzymatic digestion under nonreducing conditions on a 10 ×  14 cm × 0.8 mm polyacrylamide  (10'~: 
wt/vol) slab gel for 31/2 h at 20 mA. About 31,000 and 58,0(}0 trichloroacetic acid-precipitable  counts 
per rain were loaded in lanes A and B, respectively, and -16,000 and 29,000 trichloroacetic acid- 
precipitable counts  per rain  were loaded  in lanes C and  D, respectively. The gel was dried and 
exposed for 4 d to Kodak XRP-1 film using a Cronex Lightning Plus image-intensifying screen. The 
position of migration of the molecular weight markers for bovine serum albumin (68 K), ovalbumin 
(43  K), pepsin  (34.7 K), trypsinogen  (24  K), /~-Iaetoglobulin (18.4 K),  lysozyme (14.3 K), and 
bromophenol  blue dye (BPB) are indicated by arrows. The same result was obtained after a  14-d 
exposure of the gel. 
previously  reported  (1).  T~-I  and  T~-2  therefore  do  not  appear  to  possess  any 
subunit  structure.  Papain cleaved T~-I  (Fig. 3 C)  and T~-2  (Fig. 3 D)  into a  single 
major band that  appeared at 40,000.  It is uncertain whether an additional fragment 
migrated in the  14,000 region at or immediately above the bromophenol blue marker 
dye.  Several  smaller  i2aI-labeled  peptides  as  well  as  residual  free  t25I  could  also 
electrophorese in this region. A  higher percentage aerylamide slab gel (e.g.,  15%  wt/ 
vol)  may be necessary to  resolve this uncertainty. Thus,  these AEF Tn  components 
are  cleaved  by  papain  into  a  40,000  tool  wt  fragment  and  perhaps  lower  tool  wt 
peptides. Several small peptides but no larger fragments are obtained by digestion of 
T~-I  and T~-2 with other proteases such as pepsin and trypsin. 
Since TX~-I and TX~-2  are proteins of 68,000  tool wt that differ by only 0.3 pI U  in 
their net charge, we checked whether their charge difference could be accounted for 
by  either  altered  amounts  of  glycosylation  and/or  phosphorylation.  125I-labeled 
T~-I  and  T~-2  were  analyzed by IEF  (11)  before and  after incubation with either 
neuraminidase or alkaline phosphatase. Clusters of about  five major IEF bands were 
observed  for  both  undigested T~-I  and  T~-2  (data  not  shown).  The T~-I  cluster 
appeared in the pI 5.7-5.9 range and the T~-2  cluster in the pl 5.4-5.7 range. These 
pI values are consistent with  the  pI  5.8 and  pI 5.5  values estimated by chromatofo- DELOVITCH ET AI,.  1801 
cusing of T~-I  and  T~-2,  respectively.  Treatment  of T~-I  and T~-2  with  either 
neuraminidase  or alkaline  phosphatase did  not cause any charge shifts  in their  IEF 
patterns.  It  is  unlikely,  therefore,  that  the  charge  difference  between  T~-I  and 
T~-2  is  attributable  to a  posttranslationally  altered  amount  of sialylation  or phos- 
phorylation  of these  two  proteins.  However,  the  possibility  that  the  muhiplicity  of 
IEF bands  observed  for these  proteins  results  from microheterogeneities  introduced 
during  radioacylation  (14)  and/or  from  alternate  forms of glycosylation cannot  be 
ruled out. 
To determine  whether  any of the  charge  heterogeneity  between T~-I  and T~-2 
results  from a  difference in their amino acid sequence,  these proteins were subjected 
to  a  method  of  peptide-mapping  analysis  designed  for  picomolar  quantities  of 
radioiodinated  protein  (14).  125I-labeled reduced and alkylated T~-I  and T~-2  were 
rechromatofocused to remove minor contaminants such as IL-2 and were then digested 
to completion  with  trypsin  (5).  Under  these conditions,  protein  acylation  results  in 
derivatized  lysine residues  that are resistant  to trypsinization,  and proteolysis occurs 
only at  arginine  and  alkylated  cysteine residues.  The sensitivity  and  reproducibility 
of this  peptide-mapping  technique  was previously checked by comparative analyses 
of the maps of mouse serum albumin  (MSA)  and bovine serum albumin  (BSA)  and 
of alloreactive and self-reactive/-J-restricted  AEF TH components (5). 
125I-labeled  tryptic  peptides  were separated  on  IEF gels  using  a  pH  gradient  of 
4-9.7  (Fig.  4).  Nine  peptides  of Tt~-I  and  eight  peptides  of T~-2  were  observed. 
Seven of nine peptides  (-80%)  are shared  between T~-I  and T~-2, T~-I  contains 
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FI~. 4.  Tryptic peptide  maps of 12~I-labeled T~-L  and T~-2. Aliquots (250 ng) of t~t-labeled 
IA  IA  TH- 1 and Tn-2 were reductively methylated, alkylated, and digested with 10 #g of L(tosylamide-2- 
phenyl)-ethyl-chloromethyl-ketone (TPCK) trypsin in 0.1 M NH4HCO3 for 3 h at 37°C, using 500 
#g ofovalbumin as carrier. An additional 10 #g of  TPOK-trypsin was then added and the incubation 
continued for 15 h at 37°C. Samples were lyophilized, resuspended, and focused on  11 × 0.6 cm 
tube gels for 16 h at 400 V in the pH range of  4-10. Gel slices (1 ram) were cut and the radioactivity 
determined in a y-counter. A background level of radioactivity (40 cpm) was subtracted  from all 
samples. The pH of 2-ram gel slices of a tube gel run simultaneously in parallel is shown. To align 
the peptide maps, the pH of the peak fractions of each peptide detected was measured. T~-1  and 
T~A-2 peptides that differ from each other are designated by arrows. 1802  /-A-RESTRICTED  ALLOGENEIC  EFFECT  FACTOR  MOLECULES 
TABLE  II 
Serological Analysis of T~-I and T~-2 
Antibody 
CPM pre~:ipitated* 
T~-I  T~-2 
AF.3.44.4 (anti-TnF)  492  423 
F 30.60 (anti-TsF)  485  402 
Normal rat serum  +  347  396 
None  +  228  258 
* To 80/d of PBS containing 50,000 cpm of either T~- 1 or T~-2  was added 
either 20/~1 of anti-TnF ascites (330 ~g IgM/ml) or  1 ittl of anti-TsF ascites 
(16 mg IgG/ml). Reaction mixtures were incubated overnight at 4°C, 20/.d 
of affinity-purified F(ab')2 of rabbit anti-rat Fab (3 mg IgG/ml) added, and 
the incubation extended for 8 h  at 4°C. Subsequently, 100/d of a  goat anti- 
rabbit  IgG was added to the mixtures. Reactions were terminated after an 
additional  16 h  at 4°C by centrifugation at 6,300 g for 5 min. Immunopre- 
cipitates were washed five times with  1 ml of PBS containing 0.5% Nonidet 
P-40, 0.1% SDS, 5 mM KI, and 0.5 mM phenylmethylsulfonyl fluoride, air 
dried, and their radioactivity determined in a  y-counter. 
:~ Control  samples were  either reacted  with  5/d  of Lewis normal rat  serum 
instead of the rat monoclonal antibodies, or otherwise treated with only the 
second and third step reagents. 
two peptides absent from T~-2, and T~-2  contains one peptide absent from TX~-I. 
Thus, it seems that T~-I  and T~-2 are homologous but nonidentical proteins, and 
that  a  small  number of amino  acid  interchanges  in  their primary structure  might 
account for some of their net charge difference. 
An earlier serological analysis  (1)  of an alloreactive, /-A-restricted, AEF Tn com- 
ponent demonstrated that it does not bear any Ia, VH, Cn or L chain determinants. 
Similar results were obtained with the T~-I  and T~-2  isolated and characterized in 
this study. Other studies conducted with heteroantisera and monoclonal antibodies, 
produced against either TH or Ts factors, have suggested by analogy to Ig molecules 
that  factors  bear  isotypic  determinants  in  their  "constant  region"  (reviewed  in 
reference 3).  Accordingly, it  was  of interest  to  examine T~-I  and T~-2  for their 
expression of such putative isotypic determinants. 
Aliquots  of  lzSI-labeled  T~-I  and  T~-2  were  incubated  with  rat  monoclonal 
antibodies reactive with either a KLH-specific TnF or a KLH-specific Ts factor (TsF) 
(3).  Immunoprecipitates were formed using F(ab')2 of rabbit  anti-rat  Fab and  goat 
anti-rabbit IgG. Table II shows that no specific precipitation was obtained with anti- 
THF and  anti-TsF.  TsF  does  not  share  epitopes  with  THF  (3)  and  would  not  be 
expected to share  epitopes with T~-I  and T~-2.  Although  rat  anti-THF  does  not 
react with T~-I and T~-2, the possibility remains that THF,T~-I, andT~-2  express 
another as yet undetected epitope(s) in common. 
Discussion 
The/-A-restricted alloactivated responder TH cell-derived AEF helper component 
that we previously characterized (1) was primarily alloreactive in its specificity but it 
also possessed self-reactivity, albeit considerable less. It is conceivable that this pattern 
of anti-Ia-like cross-reactivity was mediated by either a  single T  cell molecule or by 
two different T  cell molecules each with a distinct specificity. We therefore attempted 
to increase the level of purification of this AEF alloreactive TH component with the DELOVITCH  ET  AL.  1803 
aim  (a)  to  determine  if it  were  possible  to  biochemically  resolve  an  alloreactive 
component from a self-reactive component; (b) to identify the target cell and mecha- 
nism of action of the alloreactive and self-reactive components; and  (c) to gain more 
insight into the molecular basis of T  cell alloreactivity and self-reactivity. 
Using a method of fractionation of AEF that involved chromatography on ACA 54 
and two stages of chromatofocusing, we separated an I-A k-restricted alloreactive TH 
component  (T~-I) of 68,000 tool wt and pI 5.8 from an/-AS-restricted self-reactive 
component TIA-2 of 68,000 mol wt and pI 5.5 (Table III). The principle of this simple 
fractionation scheme is similar to that used in two-dimensional (2-D) gel electropho- 
resis, which separates proteins on the basis of molecular size and charge. Proteins such 
as Ia antigens that are resolved by 2-D gels may be highly purified, and when cut out 
of such gels, digested, and analyzed, yield a homogeneous tryptic peptide profile (15). 
The level of purification achieved here forT~-I andTt~-2  was estimated to be ~900- 
fold. Before peptide-mapping analyses, this amount of purification was presumably 
enhanced still further after a  third chromatofocusing ofT~-I  and T~-2  to remove 
contaminating  IL-2.  Elution  of T~-I  and  T~-2  activity  from  the  68,000  mol  wt 
region  of an  SDS  slab  gel  should  enable  us  to conclude unequivocally that  these 
helper activities are conferred by 68,000 tool wt proteins. 
The  biochemical  fractionation  scheme  adopted  here  provided  three  additional 
advantages  over  the  one  previously  used.  First,  chromatofocusing  is  more  rapid, 
efficient, and easier to perform (5)  than the horizontal flat bed and vertical column 
IEF techniques previously used (1). Second, the high degree of resolution achieved by 
chromatofocusing of proteins of very similar molecular charge permitted the separa- 
tion  of the  T~-2  self-reactive component;  this  degree of resolution was  not  easily 
obtained  with  the  methods  of IEF  used  previously  (1).  Third,  chromatofocusing 
eliminated  the  use of Ampholines  (LKB Instruments,  Inc.,  Rockville,  MD)  which 
invariably deplete  AEF  Tn  activity,  perhaps  by denaturing T~-I  and T~-2  and 
lowering their relative affinity for their respective I-A determinants. Since T~-I  and 
T~-2 are generated by the allostimulation of responder T cells and since alloactivation 
both in vivo and in vitro are required to detect the activity of these proteins (reviewed 
in  reference 5),  the  affinity of interaction between T~-I  and  allo-Ia determinants 
may be higher than that between T~-2 and self-Ia determinants. AlthoughT~-1  and 
TI~-2 were isolated with approximately the same yield (i.e., ~1 /tg/108 activated T 
cells) and are both active in the 1 pmol concentration range, the ability to detect their 
biological activity after various methods of fractionation presumably depends on their 
TABLE  III 
Properties of T[~ l  and  T~2 
Property  T~- 1  T~-2 
Molecular weight  68,000  68,000 
pI  5.8  5.5 
Papain-cleavage fragments  40,000  40,000 
Percent shared peptides  80  80 
Cellular origin  Lyt-  1  +2-TH cell  Lyt-  1  +2-Tr~ cell 
Target cell  I-A k APC  I-A 8 APC 
Recognition of  I-A determinants  AIIo-/-A  k  Self-/-A  s 
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recovery with suitably high affinity for their target antigens. 
Peptide-mapping  analyses revealed  that T~-I  and T~-2  share  ~80%  of their 
tryptic peptides.  However, only a  limited number of peptides (eight  or nine)  were 
observed for these proteins as a result of labeling them in their arginine and alkylated 
cysteine residues.  Resolution of peptides derived by tryptic digestion of T~-I  and 
T~-2 labeled biosynthetically in their leucine and arginine residues might ultimately 
reveal more peptide heterogeneity between these two proteins.  By analogy to tryptic 
peptide analyses of H-2K and H-2D proteins (16), an 80% degree of peptide sharing 
suggests that T~-1  and T~-2 are 90-95% homologous in their amino acid sequence. 
Since T~-1 and Tx~-2 were each purified probably greater than 900-fold before being 
analyzed by peptide mapping, it appears that T~-I  and T~-2  are homologous but 
nonidentical proteins.  Further purification and characterization ofT~-I  and T~-2 
should confirm whether T~-I and T~-2 are structurally different. 
The/-A-restricted T~-1  and T~-2 polypeptides differ structurally from the previ- 
ously described /-J-restricted self-reactive  (rI~-l)  and alloreactive (Tlan-2) AEF TH 
components produced  across  an l-J  incompatibility (5). Whereas TI~-I  and TI~-2 
share 80% of their tryptic peptides, these proteins share only 50-60% of their tryptic 
peptides with either T~- 1 or T~-2. These four different proteins may therefore possess 
as much as  70-80% amino acid sequence homology. If they constitute the secreted 
forms  of distinct T  cell  surface-associated  Ia antigen receptors  (1,  5),  then T  cell 
receptors  for a given set of related antigens may be structurally quite homologous to 
each  other.  The  suggested  high  degree of homology of self-Ia  and  allo-Ia T  cell 
receptors  is consistent with the hypothesis that T  cell alloreactivity originates from 
cross-reactions  of self-reactive T cells (17-21). 
Papain, when incubated at 5 #g/ml for 1 h  at 37°C with T~-I  and T~-2, splits 
these proteins into a single 40,000 tool wt fragment. A 20-30,000  mol wt fragment 
was not observed  under these conditions or during digestion for 5-30  min at 37°C 
with 1 #g/ml of the enzyme (data not shown). The latter conditions resulted in 40,000 
mol wt fragments that constituted ~ 75% of  the digested product. The papain digestion 
pattern of T~- 1 and T~-2 indicates that these proteins may differ structurally from 
another putative alloactivated T cell receptor that is split by plasmin into 45,000 and 
25,000 tool wt fragments (22) and from an antigen-specific Ts molecule that is cleaved 
by papain into 45,000 and 24,000 tool wt fragments (13). The 25,000 mol wt fragment 
of the alloactivated T cell molecule has antigen-binding capacity, although the nature 
of the antigen (H-2 or Ia molecules) is undefined (22). The Ts molecule 45,000 tool 
wt fragment specifically  suppresses  and lacks antigen-binding activity while the Ts 
molecule 24,000 mol wt fragment does not suppress but has antigen-binding activity. 
By contrast, our preliminary data  (not shown)  indicate that  the T~-I  and T~-2 
40,000 mol wt fragments do not have any Tn activity and therefore probably do not 
retain their ability to recognize/-A-encoded determinants. Thus, antigen-specific T 
cell molecules may differ structurally from alloantigen-specific T cell molecules. 
The cellular origin of T~-I and T~-2 is most probably an Lyt-l+2  -  alloactivated 
responder T cell. This reasoning follows from the fact that these proteins are derived 
from mixed lymphocyte reaction (MLR) cultures of responder cells that were >90% 
GVHR-donor T  cell in origin and from irradiated stimulator spleen  cells that were 
depleted of T  cells. GVHR- and MLR-activated T  cell blasts that have TH activity 
bear the Lyt-1+2  - surface antigen phenotype (6). It shall prove interesting to determine DELOVITCH ET AL.  1805 
whether T~-1 and T~-2 are products of the same or, as expected, different activated 
Tn cells. 
The notion that self-Ia and allo-Ia receptors appear on distinct activated T  cells, 
and  that  such  receptors differ structurally perhaps  due to somatic mutation,  is  in 
concert  with  recent  evidence  that  suggests  that  precursor  Y  cells  express  anti-Ia 
receptors before their entry into  the  thymus  (23).  In  an  immunologically tolerant 
environment, precursor T  cells may recognize allo-Ia determinants and be rendered 
nonfunctional. However, during an allogeneic stimulation in a nontolerant environ- 
ment, such as that which occurs in a GVHR used in the first stage of AEF production, 
a subpopulation of donor thymocytes that express self-Ia (i.e., anti-donor Ia) receptors 
are probably stimulated  in  the irradiated  host  environment to express allo-Ia  (i.e., 
anti-host Ia) receptors. Subpopulations ofGVHR-activated T cells that express either 
self-Ia receptors or allo-Ia receptors can in fact be found (6). Future structural studies 
of products of clones of alloactivated /-A-restricted TH cells should  assist  with  the 
further elucidation of this problem. 
Functional analyses of T~-1  and TX~-2 demonstrated that T~-1  recognizes allo-/- 
A-encoded  determinants  on  an  APC  of the  stimulator  haplotype  and  that T~-2 
recognizes self-LA-encoded determinants on an APC of the responder haplotype. The 
genotype of the APC and not the B cell proved important forT~-1 andTt~-2 activity. 
These observations are compatible with those that indicate that the genotype of the 
APC and not the T  cell dictates the specificity of an antigen-induced T  cell prolifer- 
ative response (21, 24).  The data obtained herein with polyclonally alloactivated Tn 
cell-derived  Ia-specific  molecules  and  those  obtained  with  antigen-specific  T  cell 
clones imply that during an antibody response to a  given antigen, binding of the T 
cell antigen receptor and Ia molecule to the antigen, possibly in the form of a ternary 
complex (21), imparts antigenic specificity to the response. 
Finally, our data suggest that a TH/APC interaction such as that which may occur 
in the presence of antigen between either T~-I  or T~-2  and an appropriate APC, 
elicits a secondary interaction or signal transfer between an APC and a B cell. Thus, 
TH/APC interaction might stimulate the synthesis and secretion of an APC- and/or 
Tn  cell-derived soluble product(s)  that  binds  to  and  activates  a  B  cell  in  an  I-A- 
nonrestricted and either antigen-specific or nonspecific manner  (9).  The characteri- 
zation of B  cell-activating molecules released subsequent  to TH-APC interaction is 
currently under investigation. 
Summary 
An allogeneic effect factor (AEF) derived from mixed lymphocyte reaction (MLR) 
cultures ofalloactivated A.SW (H-2 ~) responder T cells and irradiated T cell-depleted 
A/WySn (H-2 '~) stimulator spleen cells was fractionated on the basis of molecular size 
and  charge into  two /-A-restricted helper components.  The cellular origin of these 
components is believed to be an Lyt-1  +2--activated responder T  helper (Tu) cell. One 
alloreactive  component,  TInA-1, recognizes  allo-/-A  determinants  on  an  A/WySn 
antigen-presenting cell (APC).  The other self-reactive component, T~-2, recognizes 
self-/-A determinants on an A.SW APC. The interaction of each of these components 
with the appropriate APC subsequently activates an in vitro primary anti-SRBC PFC 
response of either stimulator haplotype- or responder haplotype-derived B cells. These 1806  /-A-RESTRICTED  ALLOGENEIC  EFFECT  FACTOR MOLECULES 
data demonstrate  that the activity of T~-I  and T~-2  is dependent  on the genotype 
of the  APC and  not  the  B  cell,  and  that  the  target  cell  of action of these AEF TH 
components is an APC. 
T~- 1 and T~-2 are 68,000 tool wt single polypeptide chains that have an isoelectric 
point  (pI)  of 5.8 and  5.5, respectively.  Their charge difference  is not attributable  to 
altered amounts of sialylation or phosphorylation, but probably is due to other forms 
of altered  glycosylation and/or to changes in their amino acid sequence. They share 
~80%  of their  tryptic  peptides  and  likely  constitute  homologous but  nonidentical 
molecules.  Papain cleaves T~- 1 and TIl~-2  into a  40,000 mol wt fragment. T~- 1  and 
T~-2  may  represent  structurally  very  related  but  nonidentical  secreted  forms  of 
activated  responder TH cell-derived  receptors  for allo-/-A and self-/-A determinants, 
respectively. 
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